Ton Lisman Selected Research

Ton Lisman Research Topics

Disease

48	Hemorrhage 01/2022 - 03/2002
45	Fibrosis (Cirrhosis) 07/2022 - 03/2002
42	Liver Diseases (Liver Disease) 09/2022 - 07/2006
33	Thrombosis (Thrombus) 01/2022 - 03/2006
9	Thrombophilia 01/2022 - 02/2005
8	COVID-19 10/2021 - 10/2020
8	Thrombocytopenia (Thrombopenia) 01/2021 - 02/2008
7	Inflammation (Inflammations) 07/2022 - 07/2009
7	Acute Liver Failure (Fulminant Hepatic Failure) 07/2022 - 06/2010
7	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 05/2007
7	End Stage Liver Disease 09/2020 - 01/2007
6	Acute-On-Chronic Liver Failure 07/2022 - 09/2020
5	Hemophilia A (Haemophilia) 05/2022 - 01/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 03/2007
5	Pathologic Constriction (Stenosis) 01/2015 - 08/2011
4	Hepatic Encephalopathy 03/2022 - 04/2016
4	Portal Hypertension 01/2022 - 01/2007
4	Myocardial Infarction 10/2021 - 06/2009
4	Reperfusion Injury 09/2021 - 08/2012
4	Ischemia 01/2019 - 08/2011
4	Non-alcoholic Fatty Liver Disease 02/2017 - 01/2015
3	Neoplasms (Cancer) 01/2022 - 09/2004
3	Disease Progression 01/2022 - 01/2015
3	Critical Illness (Critically Ill) 01/2022 - 01/2021
3	Disease Susceptibility (Diathesis) 01/2014 - 03/2002
3	Thrombasthenia (Glanzmann Thrombasthenia) 04/2008 - 03/2003
2	Pulmonary Embolism 10/2021 - 08/2004
2	Wounds and Injuries (Trauma) 10/2021 - 03/2017
2	Sepsis (Septicemia) 01/2021 - 06/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 11/2007
2	Disseminated Intravascular Coagulation 01/2019 - 03/2017
2	von Willebrand Diseases (von Willebrand's Disease) 01/2018 - 03/2007
2	Liver Failure 03/2017 - 08/2010
2	Obesity 11/2016 - 06/2016
2	Fatty Liver 11/2016 - 09/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2016 - 07/2009
2	Hepatitis B 02/2015 - 01/2015
2	Hepatitis 01/2015 - 03/2010
2	Sclerosing Cholangitis 04/2014 - 09/2011
1	Leg Injuries (Leg Injury) 01/2022
1	Brain Death (Brain Dead) 01/2022
1	Ascites 01/2022
1	Virus Diseases (Viral Diseases) 10/2021

Drug/Important Bio-Agent (IBA)

53	Hemostatics (Antihemorrhagics)IBA 07/2022 - 07/2006
32	AnticoagulantsIBA 07/2022 - 03/2006
23	Thrombin FDA Link 09/2022 - 04/2008
19	von Willebrand FactorIBA 07/2022 - 07/2006
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2006
12	Heparin (Liquaemin)FDA LinkGeneric 10/2021 - 08/2004
9	recombinant FVIIa (rFVIIa)FDA Link 11/2020 - 01/2002
8	Fibrinogen (Factor I)FDA Link 01/2022 - 06/2016
8	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 08/2004
7	Factor VIII (Coagulation Factor VIII)IBA 05/2022 - 06/2010
7	FibrinIBA 01/2022 - 05/2007
6	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2017
6	ThrombomodulinIBA 01/2022 - 08/2005
6	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 07/2008
6	AntigensIBA 01/2021 - 07/2006
6	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 03/2017 - 01/2002
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 08/2005
5	Thromboplastin (Tissue Factor)IBA 07/2022 - 09/2004
5	Antifibrinolytic Agents (Antifibrinolytics)IBA 07/2021 - 06/2008
5	PlasminogenIBA 03/2017 - 05/2007
5	nasIBA 01/2015 - 08/2011
4	Prothrombin (Factor II)IBA 01/2022 - 07/2013
4	Pharmaceutical PreparationsIBA 01/2014 - 01/2002
3	Oral ContraceptivesIBA 01/2022 - 05/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2004
3	Vitamin K FDA Link 01/2022 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2019
3	Plasminogen Activator Inhibitor 1IBA 10/2021 - 07/2009
3	AntithrombinsIBA 01/2021 - 12/2013
3	Fibrinolysin FDA Link 01/2021 - 01/2015
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 05/2007
3	CollagenIBA 06/2010 - 07/2006
2	AutoantibodiesIBA 05/2022 - 02/2021
2	Cell-Free Nucleic AcidsIBA 01/2022 - 09/2019
2	Thiobarbituric Acid Reactive SubstancesIBA 01/2022 - 09/2019
2	dicarboxydine (DCD)IBA 01/2022 - 10/2015
2	ThrombospondinsIBA 01/2021 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2015
2	RivaroxabanIBA 04/2015 - 01/2014
2	Fondaparinux (Arixtra)FDA Link 01/2014 - 12/2013
2	factor V LeidenIBA 09/2011 - 05/2008
2	AntibodiesIBA 02/2008 - 01/2002
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 10/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2021

Therapy/Procedure

34	Liver Transplantation 01/2022 - 03/2002
14	Therapeutics 01/2022 - 07/2013
8	Transplantation 01/2022 - 08/2013
5	Hepatectomy 12/2017 - 01/2015
3	Kidney Transplantation 12/2021 - 01/2018
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 07/2008
2	Critical Care (Surgical Intensive Care) 03/2022 - 07/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 04/2016
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022
1	Contraindications 11/2021